This study successfully optimized an electronic palliative care identification algorithm with a PPV of 80.1% and indicates appropriate palliative care penetration rates may be as high as 26.4% of the total inpatient population.
rehabilitation (SAR). Hospital administrators are currently working to design programs to decrease hospital re-admittance rates for chronically ill patients. The purpose of this study is to describe the characteristics of patients who received a palliative care consultation (PCC) at one SAR and describe the outcomes of these consults. Research Objectives. To evaluate clinical outcomes of patients who receive palliative care consultation while residing in a sub-acute rehabilitation (SAR) facility.
these results, we have designed a pilot qualitative study to understand perspectives from patients, caregivers, and healthcare providers with regards to challenges and opportunities in identifying and managing patients with end-stage liver disease. In the second part of the session, we will review the results of this pilot study and review the specific challenges and opportunities identified. Lastly, we will explore key elements of research design and intervention development for this population necessary to further research in this area of critical need.
of palliative care and a communication component focusing on leading code status discussions and family meetings about goals of care. AAHPM workshop participants will have an opportunity to experience some of the curriculum elements in an interactive fashion. Outcomes data will be shared about the curriculum content, effectiveness of the IP curriculum and instructional design, and the impact on IP attitudes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.